VICTORIA MANN: Open Payments
NPI 1952022857 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,274 in 76 payments from 16 companies in 2025. Trend: 2023 $934 · 2024 $1,431 · 2025 $1,274
Food & beverage: $1,175Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $237 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 19 | $172 |
| Janssen Biotech, Inc. | 5 | $171 |
| Aimmune Therapeutics, Inc. | 6 | $136 |
| PFIZER INC. | 3 | $98 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $82 |
| Ardelyx, Inc. | 4 | $77 |
| Regeneron Healthcare Solutions, Inc. | 2 | $51 |
| GENZYME CORPORATION | 2 | $42 |
| Madrigal Pharmaceuticals | 2 | $42 |
Products named: XIFAXAN, TREMFYA, ZENPEP, RINVOQ, DUPIXENT, ENTYVIO, IBSRELA, LINZESS.
Industry payments across TN — which companies pay providers there.
